Synairgen (SNG) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 May 2020 05:07 PM
RNS
Holding(s) in Company
05 May 2020 11:05 AM
RNS
Second Price Monitoring Extn
05 May 2020 11:00 AM
RNS
Price Monitoring Extension
30 Apr 2020 12:09 PM
RNS
Extension of clinical study in COVID-19 patients
28 Apr 2020 05:16 PM
RNS
Holding(s) in Company
24 Apr 2020 05:10 PM
RNS
Holding(s) in Company
16 Apr 2020 05:35 PM
RNS
Holding(s) in Company
15 Apr 2020 01:30 PM
RNS
Holding(s) in Company
14 Apr 2020 02:06 PM
RNS
Second Price Monitoring Extn
14 Apr 2020 02:00 PM
RNS
Price Monitoring Extension
14 Apr 2020 12:00 PM
RNS
Result of General Meeting
14 Apr 2020 11:06 AM
RNS
Second Price Monitoring Extn
14 Apr 2020 11:00 AM
RNS
Price Monitoring Extension
14 Apr 2020 09:00 AM
RNS
Price Monitoring Extension
08 Apr 2020 04:41 PM
RNS
Second Price Monitoring Extn
08 Apr 2020 04:36 PM
RNS
Price Monitoring Extension
01 Apr 2020 04:56 PM
RNS
Holding(s) in Company
31 Mar 2020 05:58 PM
RNS
Holding(s) in Company
31 Mar 2020 04:42 PM
RNS
Second Price Monitoring Extn
31 Mar 2020 04:36 PM
RNS
Price Monitoring Extension
31 Mar 2020 07:00 AM
RNS
Commencement of dosing in COVID-19 trial
30 Mar 2020 04:42 PM
RNS
Second Price Monitoring Extn
30 Mar 2020 04:36 PM
RNS
Price Monitoring Extension
30 Mar 2020 11:05 AM
RNS
Second Price Monitoring Extn
30 Mar 2020 11:00 AM
RNS
Price Monitoring Extension
30 Mar 2020 09:05 AM
RNS
Second Price Monitoring Extn
30 Mar 2020 09:00 AM
RNS
Price Monitoring Extension
27 Mar 2020 03:21 PM
RNS
Holding(s) in Company
26 Mar 2020 09:00 AM
RNS
Result of Fundraising
25 Mar 2020 01:45 PM
RNS
Proposed Fundraising
25 Mar 2020 11:05 AM
RNS
Second Price Monitoring Extn
25 Mar 2020 11:00 AM
RNS
Price Monitoring Extension
25 Mar 2020 08:24 AM
RNS
Holding(s) in Company
23 Mar 2020 11:05 AM
RNS
Second Price Monitoring Extn
23 Mar 2020 11:00 AM
RNS
Price Monitoring Extension
23 Mar 2020 09:05 AM
RNS
Second Price Monitoring Extn
23 Mar 2020 09:00 AM
RNS
Price Monitoring Extension
20 Mar 2020 04:48 PM
RNS
Second Price Monitoring Extn
20 Mar 2020 04:40 PM
RNS
Price Monitoring Extension
20 Mar 2020 02:00 PM
RNS
Price Monitoring Extension
19 Mar 2020 02:06 PM
RNS
Second Price Monitoring Extn
19 Mar 2020 02:01 PM
RNS
Price Monitoring Extension
19 Mar 2020 09:05 AM
RNS
Second Price Monitoring Extn
19 Mar 2020 09:00 AM
RNS
Price Monitoring Extension
18 Mar 2020 07:00 AM
RNS
Synairgen to start trial of SNG001 in COVID-19
10 Mar 2020 04:36 PM
RNS
Price Monitoring Extension
17 Oct 2019 03:53 PM
RNS
Holdings in Company
16 Oct 2019 07:30 AM
RNS
Holding(s) in Company
30 Sep 2019 07:00 AM
RNS
Half-year Report
27 Sep 2019 07:00 AM
RNS
Phase II Biomarker Data for SNG001 to be presented

Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.

Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.

Synairgen share price launched at 155p in 2004.

UK 100

Latest directors dealings